1965. Safety and Efficacy of Glecaprevir/Pibrentasvir in Patients With Chronic Hepatitis C Virus Genotypes 1–6 and Human Immunodeficiency Virus-1 Co-Infection: An Integrated Analysis of Two Phase 3 Clinical Trials

Integrated Analysis ◽

Phase 3 ◽

Two Phase ◽

Safety And Efficacy ◽

Immunodeficiency Virus ◽

Chronic Hepatitis C Virus ◽

Virus Genotypes ◽

Hepatitis C Virus Genotypes ◽

Primary Efficacy Endpoint and Safety Results of Ibalizumab in a Phase 3 Study of Heavily Treatment-Experienced Patients With Multidrug-Resistant Human Immunodeficiency Virus-1 Infection

Open Forum Infectious Diseases ◽

10.1093/ofid/ofw195.06 ◽

2016 ◽

Vol 3 (suppl_1) ◽

Author(s):

Jacob Lalezari ◽

W. Jeffery Fessel ◽

Shannon Schrader ◽

Princy Kumar ◽

Gary Richmond ◽

...

Keyword(s):

Multidrug Resistant ◽

Primary Efficacy ◽

Primary Efficacy Endpoint ◽

Phase 3 ◽

Immunodeficiency Virus ◽

Safety and Efficacy of Enfuvirtide for 48 Weeks as Part of an Optimized Antiretroviral Regimen in Pediatric Human Immunodeficiency Virus 1-Infected Patients

The Pediatric Infectious Disease Journal ◽

10.1097/inf.0b013e318124a9a9 ◽

2007 ◽

Vol 26 (9) ◽

pp. 799-805 ◽

Cited By ~ 19

Author(s):

Andrew Wiznia ◽

Joseph Church ◽

Patricia Emmanuel ◽

Stephen Eppes ◽

Lucy Rowell ◽

...

Keyword(s):

Safety And Efficacy ◽

Immunodeficiency Virus ◽

Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials

HIV Research & Clinical Practice ◽

10.1080/15284336.2019.1589232 ◽

2019 ◽

Vol 20 (3) ◽

pp. 73-81 ◽

Cited By ~ 2

Author(s):

Yeon-Sook Kim ◽

Shinichi Oka ◽

Ploenchan Chetchotisakd ◽

Amanda Clarke ◽

Khuanchai Supparatpinyo ◽

...

Keyword(s):

Clinical Trials ◽

Efficacy And Safety ◽

Phase 3 ◽

Immunodeficiency Virus ◽

Tenofovir Alafenamide ◽

A Phase III randomised, double-blind, multicentre study to evaluate the safety and efficacy of 1592U89 (abacavir) in human immunodeficiency virus 1-infected patients with aquired immune deficiency syndrome dementia complex

http://isrctn.org/> ◽

10.1186/isrctn53707238 ◽

2013 ◽

Author(s):

Bruce Brew

Keyword(s):

Immune Deficiency ◽

Multicentre Study ◽

Immune Deficiency Syndrome ◽

Deficiency Syndrome ◽

Phase Iii ◽

Double Blind ◽

Safety And Efficacy ◽

Immunodeficiency Virus ◽

Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT study

Chinese Medical Journal ◽

10.1097/cm9.0000000000001273 ◽

2020 ◽

Vol 133 (24) ◽

pp. 2919-2927

Author(s):

Bin Su ◽

Cheng Yao ◽

Qing-Xia Zhao ◽

Wei-Ping Cai ◽

Min Wang ◽

...

Keyword(s):

Interim Analysis ◽

Fusion Inhibitor ◽

Efficacy And Safety ◽

Phase 3 ◽

Randomized Controlled ◽

Immunodeficiency Virus ◽

Long Acting ◽

Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections

Genes and Immunity ◽

10.1038/gene.2017.2 ◽

2017 ◽

Vol 18 (2) ◽

pp. 82-87 ◽

Cited By ~ 5

Author(s):

C Vergara ◽

C Thio ◽

R Latanich ◽

A L Cox ◽

G D Kirk ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genetic Basis ◽

Immunodeficiency Virus ◽

Chronic Hepatitis C Virus ◽

PENTA18: Pharmacokinetics, safety and efficacy of lopinavir/ritonavir tablets in combination antiretroviral therapy in human immunodeficiency virus-1 (HIV-1) infected children

http://isrctn.org/> ◽

10.1186/isrctn02452400 ◽

2013 ◽

Author(s):

Elizabeth Grace Hermione Lyall

Keyword(s):

Antiretroviral Therapy ◽

Combination Antiretroviral Therapy ◽

Safety And Efficacy ◽

Immunodeficiency Virus ◽

Hiv 1 ◽

Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials

Infection and Chemotherapy ◽

10.3947/ic.2016.48.3.219 ◽

2016 ◽

Vol 48 (3) ◽

pp. 219 ◽

Cited By ~ 1

Author(s):

Jun Yong Choi ◽

Somnuek Sungkanuparph ◽

Thanomsak Anekthananon ◽

Paul Sax ◽

Edwin DeJesus ◽

...

Keyword(s):

Clinical Trials ◽

Tenofovir Disoproxil Fumarate ◽

Efficacy And Safety ◽

Phase 3 ◽

Immunodeficiency Virus ◽

Workflow Optimization of the ViroSeqTM Human Immunodeficiency Virus-1 (HIV-1) Genotyping System

Journal of Human Virology & Retrovirology ◽

10.15406/jhvrv.2015.02.00071 ◽

2015 ◽

Vol 2 (7) ◽

Author(s):

Danijela Lucic

Keyword(s):

Workflow Optimization ◽

Immunodeficiency Virus ◽

Hiv 1 ◽

Faculty Opinions recommendation of Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735541064.793559017 ◽

2019 ◽

Author(s):

Lynne Mofenson

Keyword(s):

Virus Infection ◽

Human Immunodeficiency Virus Infection ◽

Safety And Efficacy ◽

Immunodeficiency Virus